Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
about
The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal regionThe human homologue of unc-93 maps to chromosome 6q27 - characterisation and analysis in sporadic epithelial ovarian cancer.Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapyRecent concepts of ovarian carcinogenesis: type I and type IIOvarian cancer biomarker discovery based on genomic approachesThe molecular background of mucinous carcinoma beyond MUC2Impaired FHIT expression characterizes serous ovarian carcinomaStructural mutation analysis of PTEN and its genotype-phenotype correlations in endometriosis and cancerAn unsupervised learning approach to find ovarian cancer genes through integration of biological dataExpression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer.Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma.Novel three-dimensional in vitro models of ovarian endometriosis.Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.Ovarian cancer: pathology, biology, and disease modelsComparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas.Investigational agents in development for the treatment of ovarian cancerHarnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacyEndometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects.Cancers, infections, and endocrine diseases in women with endometriosis.PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORSOvarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.Histotype-specific copy-number alterations in ovarian cancer.Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinomaIncidence of serous tubal intraepithelial carcinoma (STIC) by algorithm classification in serous ovarian tumor associated with PAX8 expression in tubal epithelia: a study of single institution in Japan.Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.Inducing malignant transformation of endometriosis in rats by long-term sustaining hyperestrogenemia and type II diabetes.Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.Progesterone action in breast, uterine, and ovarian cancers.Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.High-throughput detection of aberrant imprint methylation in the ovarian cancer by the bisulphite PCR-Luminex methodThe association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer.A map of human cancer signalingProgesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisEstablishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability.The Notch pathway in ovarian carcinomas and adenomas.Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomasAllelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma.
P2860
Q22010498-C1D87747-D78D-472A-9FDB-9ED2B20812E2Q24311419-11EC39A5-9443-40C5-92F2-4C197D502D4DQ26769604-CFAB54D0-DF5D-4A3B-A1C9-B46CC2F6CACDQ27009487-82A7A4A7-238E-4A17-822E-41ACD2C4423FQ27013687-848A956A-550C-40E0-9C8D-16C487488626Q28083904-9D882E07-94E9-48F2-B3EF-FE47AC4182D3Q28344344-0DA34075-4F76-45B3-99CC-A35EA60C9AC9Q30391301-7CB50C2F-C9C5-4717-8E6D-1985E42227A4Q30990983-EBC1C5EF-4803-4FFE-8FDA-8A12F40D09B4Q33511864-4C8B47B2-5E46-4D4E-BA41-4318BD11A0BDQ33580777-3A5C31E7-46E1-4B13-B581-D9E486A49809Q33589839-A57D3C86-F1B4-4C26-B14A-7BDA8C34C9C1Q33778612-B34F93A5-4D87-4CDB-951C-25478FCB5CECQ33807748-EFB16F54-3BE2-4217-B828-F724CE411F62Q33890039-91408DF1-26B7-41E6-BABD-9A18B11938FBQ33920800-504038CA-1EF5-483A-8E11-531308F80DE9Q34005179-C0052CAD-A2C8-41A3-9E43-C55CB8E8D61CQ34033619-6A6584BD-706C-4DDD-8C83-CD0D64173F61Q34158879-95204414-7797-4BC8-AA96-13642CF12B8BQ34343837-493E769D-C5D7-41A7-BA4E-D79989E09837Q34350701-B47DCFD7-281C-4AFC-9947-9ECFFB723F59Q34451365-E911578A-E0A7-4EEC-8363-20297C4A8FD7Q34586019-8DCEEA36-F8EC-41FF-AE10-3C17850D54EEQ34743857-C2F92DC1-D97E-4119-99D5-AA49B4D5690EQ34977063-8D01C26F-DE2D-424C-9BB1-C1EEC2DC4A93Q35051299-28E09E8B-A67B-4446-BB5C-7D27A749B82EQ35098091-CDB353AB-01CF-4793-A127-E46BC00D9958Q35108906-7D9A5411-E6E1-4514-AAD6-427593599526Q35140600-AA00B0C1-01A0-43DF-A15D-C852FE1F2952Q35216344-DC1B2B8C-1ED9-4CB3-90F2-0DA19C695A86Q35842249-A9CE9E9D-3BDC-4CB6-9F73-33C6676B9FFFQ35927844-4F4E352B-3017-4A49-AB5B-EE7D4F8D54E0Q36242802-2A4A0A0B-E168-450B-A3F3-FCAE9D64B06CQ36327214-88CBD1AE-FDA7-4E97-B2E4-7EF9011CFEF3Q36614790-86000715-BCD0-47BC-8159-A416F8458369Q36614811-62E110D8-114D-4A88-97C6-701D900ED810Q36615348-718DA148-3161-44BA-8FA5-5EAE5ED10F05Q36622573-51D6FB77-95FA-44BC-AC2D-F4FDBD4A24FBQ36622783-CA590772-08EC-40C9-B17A-C5BE190BA172Q36623673-098BB0AD-9E02-40D8-A38F-01247638D2A8
P2860
Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Frequent PTEN/MMAC mutations i ...... ous epithelial ovarian tumors.
@en
Frequent PTEN/MMAC mutations i ...... ous epithelial ovarian tumors.
@nl
type
label
Frequent PTEN/MMAC mutations i ...... ous epithelial ovarian tumors.
@en
Frequent PTEN/MMAC mutations i ...... ous epithelial ovarian tumors.
@nl
prefLabel
Frequent PTEN/MMAC mutations i ...... ous epithelial ovarian tumors.
@en
Frequent PTEN/MMAC mutations i ...... ous epithelial ovarian tumors.
@nl
P2093
P1433
P1476
Frequent PTEN/MMAC mutations i ...... nous epithelial ovarian tumors
@en
P2093
A Hitchcock
E J Thomas
R H Watson
S J Morland
P304
P407
P577
1998-05-01T00:00:00Z